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Abstract
Background: In this study we aimed to assess lipid peroxidation during carotid endarterectomy by the formation of 
PUFA hydroperoxides (PUFAHP) and isoprostanes (IP) and concomitant peroxisomal beta-oxidation as a physiological 
mechanism to limit their concentration. Two markers of peroxisomal beta oxidation have been evaluated, formation of 
2,3 dinor from IP and conjugated esadecadienoic acid (CD 16:2) from peroxisomal beta-oxidation of conjugated 
linoleic acid (CLA), an unusual fatty acid present in small concentration in our diet and preferentially beta-oxidised in 
peroxisomes.
The study was conducted on 30 patients undergoing carotid endarterectomy. Blood samplings were performed
before, during endarterectomy in the "ischemic phase", and 30 seconds, 30 minutes and 2 hours after reperfusion.
Results: The results showed that PUFAHP increased significantly after 30 min of reperfusion in patients with 
controlateral stenosis > 50%, and steeply decreased after 2 hour of reperfusion. Interestingly, IP increased in a similar 
fashion of PUFAHP but never significantly. Both ratios CD16:2/CLA and DIN/IP also increased significantly after 30 min of 
reperfusion to decrease thereafter.
Conclusions: Our data show that lipid peroxidation takes place only in patients with high controlateral stenosis and 
within 2 hours occurs a physiological response aimed to decrease IP and PUFAHP by increasing their catabolism in 
peroxisomes.
Introduction
Carotid endarterectomy is clinically performed to reduce
the incidence of strokes in patients with carotid stenosis
>70% [1]. However, surgery has some important compli-
cations, although rare, such as major or minor stroke and
cerebral hyperperfusion syndrome [1]. This surgical pro-
cedure involves ischemia-reperfusion, which may induce
neurooxidative stress, by free radicals formation [2-5].
Reperfused brain is particularly sensitive to oxidative
stress because of a relatively modest antioxidant defenses,
high mitochondrial density and neuronal membrane lip-
ids rich in polyunsaturated fatty acid (PUFA) side chains
which are particularly susceptible to free radical attack
triggering lipid peroxidation [3]. The primary products of
lipid peroxidation are fatty acid hydro(pero)xides among
which those derived from linoleic acid are one of the
most reliable marker [6]. Fatty acid hydroperoxides, are
quite unstable and capable to propagate free radical reac-
tions and thereby extending the damage.
One of the most widely used indirect markers of lipid
peroxidation is the detection of 8-iso-PGF2α isoprostane
(IP) [7]. Its measurement has been widely employed to a
great degree over the last decade to detect and quantify
this free radical-mediated process in a variety of biologi-
cal matrices [7].
The IP is regularly reported to be a non-enzymatic (free
radical-induced) isoprostanes, although cyclooxygenase-
2-dependent formation of small amounts of IP has been
reported [8].
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IP may be further metabolized by a combination of β-
oxidation, double bond reduction, alcohol group oxida-
tion, ω-hydroxylation and ω-oxidation, leading to a myr-
iad of metabolites, which are eventually excreted in the
urine [9-11].
One of the mechanism of protection against fatty acid
hydroperoxides and IP is their catabolism in peroxisomes
[12,13]. Peroxisomal beta oxidation occurs when fatty
acids are not a good substrate for mitochondria [14].
These unusual fatty acids include eicosanoids, isopros-
tanes, fatty acid hydroperoxides. Recently, we showed
that another unusual PUFA, conjugated linoleic acid
(CLA), with peculiar biological activities [15], widely
present in our diet because relatively abundant in dairy
products, is preferentially beta oxidized in peroxisomes
in experimental animals and humans [16]. Furthermore,
we demonstrated that in neurons and astrocytes, both in
vivo and in vitro, CLA is well absorbed and avidly beta
oxidesed in peroxisomes yielding a conjugated metabo-
lite, hexadecadienoic acid (CD 16:2) [17]. In addition, in
different experimental models we have some evidence
that during oxidative stress, the peroxisomal beta oxida-
tion of CLA increased [18]. With this study we aimed to
verify the degree and at what extent lipid peroxidation
occurs in ischemia and reperfusion during carotid endar-
terectomy, and if a physiological response occurs in terms
of increased peroxisomal beta oxidation aimed to
degrade potential dangerous lipid peroxidation products.
Carotid endarterectomies are performed under regional
anaesthesia because of easy and reliable monitoring of
cerebral perfusion.
Materials and methods
30 patients were admitted to the Hospital of the Univer-
sity of Cagliari with a carotid stenosis >70%: 17 patients
(8 women and 9 men, age 74,8 ± 4,1) presented with a
controlateral carotid stenosis >50%; 13 patients (7 women
and 6 men, age 71,5 ± 1,5) presented with a controlateral
stenosis <50%. Intra-arterial blood pressure, five-lead
electrocardiography (leads II and V5) and pulse oximetry
were commenced before placement of the anaesthetic
block and were continued during the procedure. The
patients were all submitted to the block of deep and
superficial cervical plexus, in the supine position with the
head facing away from the side to be blocked. Regional
anaesthesia was achieved using lidocaine solution 2% (10
mL) and ropivacaine 0,75% (15 mL).
The 30 surgical patients were divided into two distinct
groups according to the degree of stenosis of the internal
carotid artery controlateral to the one to be operated. The
controlateral carotid was then distinguished into two
groups according to the degree of stenosis: up to 40% and
greater than 50% (figure 1).
The degree of stenosis was evaluated by Duplex scan
and angio CT scan in all cases.
Blood samplings were performed before carotid clamp-
ing (p1), during endarterectomy in the "ischemic phase"
(p2), and 30 seconds (p3) 30 minutes (p4) and 2 hours
(p5) after reperfusion.
All Patients signed informed consensus form during
the routine anaesthesiology visit.
Blood samples (3 ml) were taken from the antecubital
veins in EDTA containing vials. The blood was immedi-
ately centrifuged at 2,000 g for 10 min. Total lipids were
then extracted and quantified from the resulting plasma
and stored as previously reported [17].
Separation of CLA and its metabolites was carried out
with an Agilent 1100 HPLC system (Agilent, Palo Alto,
CA) equipped with a diode array detector. A C-18 Inertsil
5 ODS-2 Chrompack column, (Chrompack International
BV, Middleburg, the Netherlands), 5 μm particle size, 150
× 4.6 mm, was used with a mobile phase of CH3CN/
H2O/CH3COOH (70/30/0.12, v/v/v) at a flow rate of 1.5
ml/min [19]. Conjugated diene unsaturated fatty acids,
including PUFA hydroperoxides, were detected at 234
nm. Spectra (195-315 nm) of the eluate were obtained
every 1.28 s and were electronically stored. Second-deriv-
ative UV spectra of the conjugated diene fatty acids were
generated using Phoenix 3D HP Chemstation software
(Agilent, Palo Alto, CA). These spectra were taken to
confirm the identification of the HPLC peaks [20].
IP and DIN were quantified using HPLC-MS as
described in [18].
One way ANOVA with the Tuckey test for post-hoc
analyses was applied to evaluate statistical differences
between groups.
Results
As it can be seen from figure 2, in patients with high con-
trolateral stenosis, plasma PUFAHP and IP increased
Figure 1 Percentage of controlateral stenosis of the two groups 
of patients.
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after 30' of reperfusion while decreased thereafter, but
only PUFAHP significantly.
The ratios CD 16:2/CLA and DIN/IP (figure 3)
increased significantly in a similar fashion as PUFAHP
and IP. Peculiarly, the ratio DIN/IP increased more
steeply which seems to prevent a significant increase of
IP. In patients with low controlateral stenosis no changes
of all parameters measured were detected. All the other
plasma fatty acid measured didn't change significantly
(data not shown).
Discussion
A condition of oxidative stress or other specific stimuli
can result in two different scenarios. Free radicals gener-
ated during oxidative stress may attack the esterified
PUFAs, eventually resulting in the formation of a range of
Figure 3 Changes as percentage of the values of ratios between conjugated hexadecadienoic acid (CD 16:2)and its precursor conjugated 
linoleic acid (CLA) and 2,3 dinor (DIN) and its precursor isoprostanes (IP) as a measure of peroxisomal beta oxidation, in plasma of patients 
with low controlateral stenosis (A) and high controlateral stenosis (B). Blood samplings were performed before (p1), during endarterectomy in 
the "ischemic phase" (p2), and 30 seconds (p3) 30 minutes (p4) and 2 hours (p5).
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Figure 2 Changes as percentage of the values of polyunsaturated fatty acids hydroperoxides and Isoprostanes (IP) in plasma of patients 
with low controlateral stenosis (A) and high controlateral stenosis (B). Blood samplings were performed before (p1), during endarterectomy in 
the "ischemic phase" (p2), and 30 seconds (p3) 30 minutes (p4) and 2 hours (p5). Different letters denote significant differences (p < 0.05).
0
50
100
150
200
250
300
350
p1 p2 p3 p4 p5
Fatty acid hydroperoxides
IP
a
a
b
a
B
0
50
100
150
200
250
300
350
p1 p2 p3 p4 p5
Fatty acid hydroperoxides
IP
ABanni et al. Lipids in Health and Disease 2010, 9:41
http://www.lipidworld.com/content/9/1/41
Page 4 of 5
esterified PUFA hydroperoxides. The PUFA hydroperox-
ides may then be released from the phospholipid through
the action of phospholipases. The released PUFAHP can
then be a substrate for peroxisomal beta-oxidation and
activate nuclear receptors such as peroxisome prolifera-
tors activated receptor (PPAR) alpha, a transcription fac-
tor for a series of enzymes involved in fatty acid
metabolism including peroxisomal beta oxidation [14].
The overall results is an increased peroxisomal beta-oxi-
dation which has a physiological meaning in terms of
decreasing the levels of lipid peroxidation products
potentially dangerous for cells.
A similar mechanism has been shown to occur for IP,
which is beta oxidised in peroxisomes to DIN [18].
CLA is a naturally occurring dietary fatty acid good
substrate for peroxisomal beta-oxidation yielding an
intermediate product CD 16:2 [19]. We have previously
shown that peroxisomal beta oxidation is particularly
efficient in brain [17]. Furthermore, we have shown that
CD 16:2 is promptly released from cells [19]. It is there-
fore likely that once formed in the brain CD 16:2 is then
released in the blood stream. Thereby CD16:2/CLA as
well DIN/IP are good markers of peroxisomal beta-oxida-
tion occurring in peripheral tissues [18].
During ischemia, collateral flow is a cornerstone of
cerebral blood flow (CBF) compensation. Pathways of
collateral flow include the circle of Willis, extracranial
anastomotic channels, and leptomeningeal communica-
tion that bridge "watershed" areas between major arter-
ies. During carotid endarterectomy, the risk of ischemia is
related to the dependency of the cerebral circulation on
the ipsilateral internal carotid artery and the cerebrovas-
cular reserve from the controlateral circulation.
In our conditions of ischemia-reperfusion during
endarterectomy, brain is the most likely source of these
products. Furthermore, from our data it is clear that the
significant increase occurs only 30 min after reperfusion
and only in those patients with a controlateral stenosis
greater than 50%. Interestingly the concomitant increase
of CD16:2/CLA and DIN/IP ratios are suggestive of an
increased peroxisomal beta oxidation as a physiological
response to oxidative stress resulting in a decrease of
PUFAHP and IP 2 hours after reperfusion. It is notewor-
thy that IP never increased significantly and to this is
associated a steeply increase of its catabolism in peroxi-
somes as demonstrated by the ratio DIN/IP, suggesting an
efficient physiological response to IP formation.
Therefore oxidative stress during endarterectomy,
occurs in a relatively short frame of time due to the
prompt catabolism of lipid peroxidation products.
Whether this transient oxidative stress may impair brain
function is not clear. However, a nutritional and/or a
pharmacological approach to decrease or eliminate this
transient oxidative stress in patients with a controlateral
stenosis greater than 50% may be beneficial and prevent
further brain damage. There might be different ways to
increase antioxidant status in those patients, either with a
preventive dietary intervention with antioxidants which
is preferred whenever is possible, or a direct IV interven-
tion during the surgical procedure.
In this study we hypothesize for the first time that there
is another physiological defense system against lipid per-
oxidation, suggesting that not only antioxidant mecha-
nism may play a role, but also peroxisomal beta oxidation
could synergistically help to limit oxidative stress. Proba-
bly while antioxidant systems act more on the formation
and chain propagation of free radical, peroxisomal beta
oxidation is more efficient in decreasing concentration
and exposure time to fatty acid hydroperoxides and eico-
sanoids in tissue cells. Interestingly, in brain where the
antioxidant defense is weaker, peroxisomal beta oxidation
i s  m o r e  e f f i c i e n t.  F u t u r e  s t u d i e s  o n  t h i s  d i r ec t i o n  m a y
explain some apparent discrepancies on the lack of effi-
cacy of antioxidant therapy in some disease where oxida-
tive stress is involved [21,22]. Another interesting
observation is that increased dietary omega-3 PUFAs
failed to enhance oxidative stress, despite the increased
membrane PUFAs particularly susceptible to lipid peroxi-
dation [23]. PUFA omega-3 are good ligand of PPARalpha
which once activated may increase peroxisomal beta oxi-
dation. Therefore, PUFA omega-3, despite their oxidative
susceptibility, may enhance the defense system against
lipid peroxidation by activating PPARalpha. This mecha-
nism may be particularly active in the brain where
omega-3 are the most represented PUFA family.
Therefore, our data suggest that not only antioxidants
may have a beneficial effects but also all those strategies
in increasing PUFAHP catabolism may also be efficient,
probably working synergistically. We aim to verify, by
using our experimental approach, which will be the best
strategies to avoid the occurrence of lipid peroxidation in
ischemia and reperfusion during endarterectomy under
regional anaesthesia.
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